CONTINUUM OF CARE FOR ACUTE CORONARY SYNDROME: OPTIMIZING TREATMENT FOR STEMI AND NSTE-ACS

CONTINUUM OF CARE FOR ACUTE CORONARY SYNDROME: OPTIMIZING TREATMENT FOR STEMI AND NSTE-ACS

In this EMCREG-International Monograph you will find a detailed discussion regarding the treatment of this important disease entity, acute coronary syndrome (ACS), which impacts millions of patients across the United States each year. This is a “state of the art” Monograph for emergency physicians, cardiologists, and hospitalists which provides the evidence basis for the optimal approach to treating ACS.

Read More

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2008)

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2008)

EMCREG–International is pleased to present this complimentary CME monograph providing up-to-date knowledge on the full spectrum of decision making and care for patients with acute coronary syndromes (ACS) including non-ST-segment elevation ACS (NSTE ACS) and ST-segment elevation myocardial infarction (STEMI), acute heart failure syndromes, pulmonary embolism and acute ischemic stroke.

Read More

THE EMCREG-INTERNATIONAL HYPERTENSION CONSENSUS PANEL: MANAGEMENT OF HYPERTENSIVE EMERGENCIES

THE EMCREG-INTERNATIONAL HYPERTENSION CONSENSUS PANEL: MANAGEMENT OF HYPERTENSIVE EMERGENCIES

This EMCREG-International Newsletter describe historical and physical examination findings crucial for the evaluation of end organ damage. Also provided are descriptions of hypertension associated with the following disease processes: Asymptomatic Hypertension, Acute Coronary Syndrome, Acute Heart Failure Syndromes, Neurological Emergencies, Cocaine or Amphetamine Induced Hypertension, and Aortic Dissection are provided with treatment recommendations. Through collaboration with colleagues from a variety of specialties, patients with hypertension can receive optimal therapy when presenting to any acute care setting.

Read More

DIRECT THROMBIN INHIBITORS IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES

DIRECT THROMBIN INHIBITORS IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES

For patients with non-ST-segment elevation acute coronary syndrome (NSTE ACS) presenting to the emergency department, appropriate anti-thrombotic and anti-platelet therapy is critical to optimize outcome. Unfractionated heparin is often given as an anti-thrombin in this setting, however, if suffers from a number of pharmacologic limitations including non-specific binding, the requirement for frequent monitoring of its anti-coagulant effect, and the formation of antibodies to the heparin/platelet factor 4/platelet complex which can cause heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia thrombosis syndrome (HITTS). Low molecular weight heparins, also an indirect thrombin inhibitor, can be used without monitoring their anti-thrombin effects. Ease of use and effectiveness makes them a popular choice in the emergency setting.

Read More

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2006)

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2006)

EMCREG–International is pleased to present this complimentary 84-page CME monograph covering the proceedings of our satellite symposium at the ACEP Scientific Assembly in New Orleans, Louisiana. A number of important topics are covered in this monograph including management of non-ST-segment elevation and ST-segment elevation acute coronary syndrome (ACS), the CRUSADE Quality Improvement Initiative, decreasing time to treatment for ST-segment elevation myocardial infarction, direct thrombin inhibitors in ACS, acute decompensated heart failure care, the use of lactate as a marker for trauma and sepsis, point-of-care testing for cardiac biomarkers, the management of hypertension in acute neurovascular emergencies and advances in acute stroke care.

Read More

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION: A SILVER LINING ON THE HORIZON?

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION: A SILVER LINING ON THE HORIZON?

We are pleased to present this cutting edge clinical update report on cardiogenic shock (CS). Acute coronary syndromes and its complications are key components of emergency medicine practice. Specifically, CS is prevalent and occurs in roughly 10% of all cases of acute myocardial infarction (AMI). Despite numerous therapeutic advances in the treatment of cardiovascular disease, CS is still the leading cause of mortality among patients with AMI. This newsletter by Drs. Jeger, Anand and Hochman summarizes the classic CS paradigm and observations from the SHOCK trial challenging that paradigm.

Read More